Effects of Empagliflozin Treatment on Glycerol‐Derived Hepatic Gluconeogenesis in Adults with Obesity: A Randomized Clinical Trial-Reference-Cited by-同舟云学术

Effects of Empagliflozin Treatment on Glycerol‐Derived Hepatic Gluconeogenesis in Adults with Obesity: A Randomized Clinical Trial

Author:

Neeland Ian J.¹^ORCID,Albuquerque Rocha Natalia¹,Hughes Connor¹,Ayers Colby R.¹,Malloy Craig R.²³⁴⁵,Jin Eunsook S.²⁵

Affiliation:

1. Division of Cardiology University of Texas Medical Center Dallas Texas USA

2. Department of Internal Medicine University of Texas Medical Center Dallas Texas USA

3. Department of Radiology University of Texas Medical Center Dallas Texas USA

4. Veterans Affairs North Texas Healthcare System Dallas Texas USA

5. Advanced Imaging Research Center, University of Texas Medical Center Dallas Texas USA

Funder

National Institute of Biomedical Imaging and Bioengineering

National Center for Advancing Translational Sciences

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

Reference25 articles.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. SGLT2 inhibitors: Beyond glycemic control;Journal of Clinical & Translational Endocrinology;2024-03

5. Blockade of sodium–glucose co-transporters improves peritoneal ultrafiltration in uraemic rodent models;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2023-05-02